Man Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $97.8M | Buy |
195,160
+148,758
| +321% | +$71.4M | 0.16% | 156 |
|
|
2026
Q1 | $22.8M | Buy |
46,402
+29,581
| +176% | +$16.1M | 0.04% | 443 |
|
|
2025
Q4 | $9.75M | Buy |
16,821
+322
| +2% | +$182K | 0.02% | 808 |
|
|
2025
Q3 | $8M | Buy |
16,499
+6,324
| +62% | +$2.94M | 0.01% | 888 |
|
|
2025
Q2 | $4.13M | Buy |
10,175
+1,697
| +20% | +$710K | 0.01% | 1130 |
|
|
2025
Q1 | $4.22M | Sell |
8,478
-10,810
| -56% | -$5.85M | 0.01% | 1088 |
|
|
2024
Q4 | $10M | Sell |
19,288
-12,056
| -38% | -$6.63M | 0.03% | 718 |
|
|
2024
Q3 | $19.4M | Sell |
31,344
-151,977
| -83% | -$90M | 0.05% | 463 |
|
|
2024
Q2 | $101M | Buy |
183,321
+170,729
| +1,356% | +$97.8M | 0.26% | 75 |
|
|
2024
Q1 | $7.32M | Sell |
12,592
-17,405
| -58% | -$9.77M | 0.02% | 832 |
|
|
2023
Q4 | $15.9M | Buy |
+29,997
| New | +$14.5M | 0.04% | 484 |
|
|
2023
Q3 | – | Sell |
-68,289
| Closed | -$36.4M | – | 259 |
|
|
2023
Q2 | $35.6M | Buy |
+68,289
| New | +$36.9M | 0.11% | 221 |
|
|
2023
Q1 | – | Sell |
-104,101
| Closed | -$58.7M | – | 72 |
|
|
2022
Q4 | $57.3M | Sell |
104,101
-18,362
| -15% | -$9.73M | 0.21% | 107 |
|
|
2022
Q3 | $62.1M | Buy |
+122,463
| New | +$68.5M | 0.29% | 68 |
|
|
2022
Q2 | – | Sell |
-211,232
| Closed | -$116M | – | 35 |
|
|
2022
Q1 | $125M | Buy |
211,232
+16,981
| +9% | +$9.75M | 0.43% | 34 |
|
|
2021
Q4 | $130M | Sell |
194,251
-35,945
| -16% | -$22.4M | 0.42% | 38 |
|
|
2021
Q3 | $132M | Buy |
230,196
+27,489
| +14% | +$15.1M | 0.46% | 37 |
|
|
2021
Q2 | $102M | Buy |
202,707
+28,162
| +16% | +$13.3M | 0.36% | 46 |
|
|
2021
Q1 | $79.7M | Buy |
174,545
+428
| +0.2% | +$204K | 0.35% | 59 |
|
|
2020
Q4 | $81.1M | Buy |
174,117
+111,361
| +177% | +$52.2M | 0.36% | 52 |
|
|
2020
Q3 | $27.7M | Buy |
62,756
+35,090
| +127% | +$14.5M | 0.11% | 198 |
|
|
2020
Q2 | $10M | Buy |
27,666
+10,384
| +60% | +$3.48M | 0.05% | 360 |
|
|
2020
Q1 | $4.9M | Sell |
17,282
-56,985
| -77% | -$18M | 0.03% | 501 |
|
|
2019
Q4 | $24.1M | Buy |
74,267
+55,650
| +299% | +$16.9M | 0.08% | 291 |
|
|
2019
Q3 | $5.42M | Sell |
18,617
-29,348
| -61% | -$8.4M | 0.02% | 830 |
|
|
2019
Q2 | $14.1M | Sell |
47,965
-30,399
| -39% | -$8.37M | 0.05% | 483 |
|
|
2019
Q1 | $21.4M | Sell |
78,364
-123,197
| -61% | -$30.7M | 0.08% | 300 |
|
|
2018
Q4 | $45.1M | Sell |
201,561
-34,964
| -15% | -$8.2M | 0.2% | 105 |
|
|
2018
Q3 | $57.7M | Buy |
236,525
+108,962
| +85% | +$25.1M | 0.21% | 87 |
|
|
2018
Q2 | $26.4M | Buy |
127,563
+75,510
| +145% | +$16M | 0.11% | 191 |
|
|
2018
Q1 | $10.7M | Buy |
+52,053
| New | +$10.9M | 0.05% | 453 |
|
Other funds holding TMO
Man Group's TMO Position: Q2 2026 in Review
Man Group increased its Thermo Fisher Scientific (TMO) stake by 321% in Q2 2026, buying an estimated $71.4M and bringing the position to 195,160 shares worth $97.8M. The position accounts for 0.16% of the portfolio, ranked #156.
Man Group first reported a position in TMO in Q1 2018 and has held it in 31 quarters since. The position peaked at $132M in Q3 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Man Group held 195,160 shares of Thermo Fisher Scientific worth $97.8M as of Q2 2026.
- Man Group bought 148,758 Thermo Fisher Scientific shares in Q2 2026, an estimated $71.4M.
- Thermo Fisher Scientific made up 0.16% of Man Group's portfolio in Q2 2026, its #156 holding.
- Man Group first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 31 quarters since.
- Man Group's Thermo Fisher Scientific position peaked at $132M in Q3 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.